Lilly Obtains Japanese Approval Recommendation For Once Weekly Byetta
This article was originally published in PharmAsia News
Executive Summary
Japan’s First Committee on New Drugs at the Ministry of Health, Labor and Welfare has recommended Eli Lilly & Co’s once-weekly Byetta (exenatide) for approval.